A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer.

PHASE2CompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

April 30, 2011

Study Completion Date

October 31, 2012

Conditions
Non-Small-Cell Lung CarcinomaAdenocarcinoma
Interventions
DRUG

Bevacizumab

Bevacizumab is available as 100 and 400 mg preservative-free, single use vials- The starting dose is 15 mg/kg, iv infusion, every 3 weeks.

DRUG

Carboplatin

Carboplatin is available as pre-mixed 10mg /ml aqueous solution- The starting dose is AUC 6 mg\*min/ml, iv infusion, every 3 weeks.

DRUG

Paclitaxel

Paclitaxel is available in multidose vials (30 mg/5ml;100mg/16.7 ml;300 mg/50ml)- The starting dose is 200 mg/m2, every 3 weeks

DRUG

AG-013736 (axitinib)

AG-013736 (axitinib) is available as 1mg, and 5 mg film-coated tablets for oral administration- The starting dose is 5 mg BID-

DRUG

Carboplatin

Carboplatin is available as pre-mixed 10mg /ml aqueous solution- The starting dose is AUC 6 mg\*min/ml, iv infusion, every 3 weeks.

DRUG

Paclitaxel

Paclitaxel is available in multidose vials (30 mg/5ml;100mg/16.7 ml;300 mg/50ml)- The starting dose is 200 mg/m2, every 3 weeks

Trial Locations (44)

14076

Pfizer Investigational Site, Caen

38119

Pfizer Investigational Site, Memphis

38120

Pfizer Investigational Site, Memphis

38133

Pfizer Investigational Site, Bartlett

38138

Pfizer Investigational Site, Germantown

38652

Pfizer Investigational Site, New Albany

38655

Pfizer Investigational Site, Oxford

38671

Pfizer Investigational Site, Southaven

38801

Pfizer Investigational Site, Tupelo

38834

Pfizer Investigational Site, Corinth

39705

Pfizer Investigational Site, Columbus

44109

Pfizer Investigational Site, Cleveland

46014

Pfizer Investigational Site, Valencia

68510

Pfizer Investigational Site, Lincoln

69495

Pfizer Investigational Site, Pierre-Bénite

70809

Pfizer Investigational Site, Baton Rouge

75230

Pfizer Investigational Site, Dallas

75235

Pfizer Investigational Site, Dallas

75246

Pfizer Investigational Site, Dallas

75679

Pfizer Investigational Site, Paris

78229

Pfizer Investigational Site, San Antonio

78284

Pfizer Investigational Site, San Antonio

79410

Pfizer Investigational Site, Lubbock

98801

Pfizer Investigational Site, Wenatchee

01201

Pfizer Investigational Site, Pittsfield

75390-8590

Pfizer Investigational Site, Dallas

180 81

Pfizer Investigational Site, Prague

390 03

Pfizer Investigational Site, Tábor

401 13

Pfizer Investigational Site, Ústí nad Labem

85-796

Pfizer Investigational Site, Bydgoszcz

80-462

Pfizer Investigational Site, Gdansk

81-519

Pfizer Investigational Site, Gdynia

87 - 100

Pfizer Investigational Site, Torun

02-097

Pfizer Investigational Site, Warsaw

03010

Pfizer Investigational Site, Alicante

08304

Pfizer Investigational Site, Mataró

08208

Pfizer Investigational Site, Sabadell

SO16 6YD

Pfizer Investigational Site, Southampton

DD1 9SY

Pfizer Investigational Site, Dundee

Pfizer Investigational Site, Dundee

LS9 7TF

Pfizer Investigational Site, Leeds

NW1 2PG

Pfizer Investigational Site, London

SW3 6JJ

Pfizer Investigational Site, London

SM2 5PT

Pfizer Investigational Site, Surrey

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY